| ACR | American College of Radiology |
| ADC | Apparent diffusion coefficient |
| AUC | Area under the curve |
| BI-RADS | Breast Imaging Reporting and Data System |
| CI | Confidence interval |
| DCIS | Ductal carcinoma in situ |
| DCE-MRI | Dynamic contrast-enhanced magnetic resonance imaging |
| DWI | Diffusion-weighted imaging |
| ER | Estrogen receptor |
| FN | False negative |
| FP | False positive |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hormone receptor |
| MRI | Magnetic resonance imaging |
| NAC | Neoadjuvant chemotherapy |
| NME | Non-mass enhancement |
| NPV | Negative predictive value |
| OR | Odds ratio |
| pCR | Pathologic complete response |
| PPV | Positive predictive value |
| PR | Progesterone receptor |
| rCR | Radiologic complete response |
| ROC | Receiver operating characteristic |
| ROI | Region of interest |
| TIC | Time-intensity curve |
| TN | True negative |
| TNBC | Triple-negative breast cancer |
| TP | True positive |
| T2W | T2-weighted |
| ΔADC | Percentage change in apparent diffusion coefficient |